Neumora Therapeutics, Inc.
Clinical trials sponsored by Neumora Therapeutics, Inc., explained in plain language.
-
New pill shows promise for bipolar II depression in small trial
Symptom relief CompletedThis pilot study tested an experimental oral medication, NMRA-335140, against a placebo in 18 adults with bipolar II disorder who were currently experiencing a major depressive episode. The goal was to see if the drug could reduce depression symptoms over 6 weeks. Participants we…
Phase: PHASE2 • Sponsor: Neumora Therapeutics, Inc. • Aim: Symptom relief
Last updated May 26, 2026 11:33 UTC
-
New depression pill shows promise in large trial
Symptom relief CompletedThis study tested an experimental oral medication, NMRA-335140, against a placebo in 383 adults with major depressive disorder. Participants took the drug or placebo daily for 6 weeks to see if it reduced depression symptoms like sadness, low energy, and loss of interest. The goa…
Phase: PHASE3 • Sponsor: Neumora Therapeutics, Inc. • Aim: Symptom relief
Last updated May 26, 2026 11:32 UTC
-
New drug aims to ease agitation in Alzheimer's patients
Symptom relief CompletedThis study tested an experimental drug called NMRA-323511 in two groups: healthy older adults and people with Alzheimer's who experience agitation. The goal was to see if the drug is safe and if it can reduce agitated behaviors like pacing or yelling. The study was small and earl…
Phase: PHASE1 • Sponsor: Neumora Therapeutics, Inc. • Aim: Symptom relief
Last updated May 22, 2026 14:01 UTC